Bolt Biotherapeutics (BOLT) — Long-term Investment Intensity
Bolt Biotherapeutics (BOLT) has a Long-term Investment Intensity of 7.6% as of December 2025. Long-term investments of $4.34 Million represent 7.6% of total assets of $56.75 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Bolt Biotherapeutics (BOLT) asset resilience to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Bolt Biotherapeutics Long-term Investment Intensity (2021–2025)
This chart shows how Bolt Biotherapeutics's Long-term Investment Intensity has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the intensity stands at 7.6%, reflecting long-term investments of $4.34 Million against total assets of $56.75 Million USD. For the complete balance sheet picture, see Bolt Biotherapeutics balance sheet assets.
Annual Long-term Investment Intensity for Bolt Biotherapeutics (2021–2025)
The table below presents the year-by-year Long-term Investment Intensity for Bolt Biotherapeutics from 2021 to 2025, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read BOLT current and long-term liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 7.6% | $4.34 Million | $56.75 Million | ▼ -15.3 pp |
| 2024 | 23.0% | $22.88 Million | $99.63 Million | ▲ +6.4 pp |
| 2023 | 16.5% | $26.41 Million | $159.78 Million | ▲ +6.0 pp |
| 2022 | 10.5% | $23.94 Million | $227.81 Million | ▼ -17.2 pp |
| 2021 | 27.7% | $85.35 Million | $307.72 Million | — |